OZURDEX

Generic: DEXAMETHASONE

Manufacturer: Abbvie

Corticosteroid [EPC]Thalidomide Analog [EPC]Proteasome Inhibitor [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Alkylating Drug [EPC]
284,534
Total Reports
127,221
Serious Reports
46,281
Death Reports
30
Reported Reactions
Death Report Ratio: High (16.27%)

Patient Demographics

Male
129,234
Female
121,741

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for OZURDEX.

# Reaction Reports % of Total
1 OFF LABEL USE 21,533
7.7%
2 FATIGUE 16,490
5.9%
3 DIARRHOEA 16,484
5.9%
4 PLASMA CELL MYELOMA 13,761
4.9%
5 NAUSEA 13,435
4.8%
6 PNEUMONIA 13,276
4.7%
7 DEATH 12,996
4.6%
8 DRUG INEFFECTIVE 12,450
4.4%
9 NEUTROPENIA 11,213
4.0%
10 PYREXIA 10,570
3.8%
11 THROMBOCYTOPENIA 10,245
3.7%
12 DYSPNOEA 9,873
3.5%
13 ANAEMIA 8,767
3.1%
14 FEBRILE NEUTROPENIA 8,691
3.1%
15 ASTHENIA 8,489
3.0%
16 VOMITING 8,471
3.0%
17 NEUROPATHY PERIPHERAL 8,243
2.9%
18 RASH 7,941
2.8%
19 DISEASE PROGRESSION 7,267
2.6%
20 CONSTIPATION 6,701
2.4%
21 SEPSIS 5,970
2.1%
22 DECREASED APPETITE 5,868
2.1%
23 PLATELET COUNT DECREASED 5,739
2.1%
24 HEADACHE 5,517
2.0%
25 DIZZINESS 5,353
1.9%
26 PAIN 5,332
1.9%
27 INFECTION 5,117
1.8%
28 HYPOTENSION 4,782
1.7%
29 MALAISE 4,671
1.7%
30 ACUTE KIDNEY INJURY 4,631
1.7%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.